BackgroundCheck.run
Search For

Brian N Zeiler, 57418 Beech St, Township Of Washington, NJ 07676

Brian Zeiler Phones & Addresses

418 Beech St, Township of Washington, NJ 07676    201-3588523   

Washington Twps, NJ   

Wyckoff, NJ   

Bluemont, VA   

Hackensack, NJ   

Encino, CA   

Glen Rock, NJ   

Coconut Creek, FL   

Port Allen, LA   

Twp Washinton, NJ   

326 Prospect Ave APT 12C, Hackensack, NJ 07601   

Mentions for Brian N Zeiler

Brian Zeiler resumes & CV records

Resumes

Brian Zeiler Photo 11

Brian Zeiler

Skills:
Institutional, Sales, Airflow, Institutional Sales
Brian Zeiler Photo 12

Brian Zeiler

Brian Zeiler Photo 13

Brian Zeiler

Publications & IP owners

Us Patents

Compositions And Methods For Binding Agglomeration Proteins

US Patent:
2005026, Nov 24, 2005
Filed:
Apr 22, 2005
Appl. No.:
11/113440
Inventors:
Abraham Grossman - Pleasantonville NY, US
Valentine Kryukov - Pushino, RU
Brian Zeiler - Glen Rock NJ, US
Assignee:
Q-RNA - New York NY
International Classification:
C07H021/02
US Classification:
536023100
Abstract:
Amplibody compositions and methods used to interact with agglomeration proteins and initiate and mediate an aggregation cascade are disclosed herein. Compositions herein comprise one or more DNA or RNA molecules having affinity for at least one agglomeration protein. The nucleic acid component is a naturally occurring or non-naturally occurring molecule with twenty or more ribonucleotide bases. For RNA, at least one nucleotide sequence portion of this RNA molecule has affinity to at least one consensus sequence present in the agglomeration RNA-binding protein. The isolated RNA molecules of the present invention bind agglomeration proteins to initiate and mediate the progression of a nucleo-protein aggregation cascade. The nucleo-protein aggregation cascade can be self-catalyzing, with formation of intermediate aggregates comprising an RNA molecule and one or more agglomeration proteins.

Compositions And Methods For Binding Agglomeration Proteins

US Patent:
2005026, Dec 1, 2005
Filed:
Apr 22, 2005
Appl. No.:
11/112929
Inventors:
Abraham Grossman - Pleasantville NY, US
Valentine Kryukov - Puschino, RU
Brian Zeiler - Washington Township NJ, US
Assignee:
Q-RNA - New York NY
International Classification:
C12Q001/70
C12Q001/68
US Classification:
435005000, 435006000
Abstract:
Amplibody compositions and methods used to interact with agglomeration proteins are disclosed herein. Compositions herein comprise one or more DNA or RNA molecules having affinity for at least one agglomeration protein. The nucleic acid component is a naturally or non-naturally occuring molecule with twenty or more ribonucleotide bases. For RNA, at least one nucleotide sequence portion of this RNA molecule has affinity to at least one consensus sequence present in the agglomeration RNA-binding protein. The portion of nucleotide sequence of RNA having affinity for agglomeration proteins is a sequence that is derived from either and RNA virus, and RNA agglomeration proteins is a sequence that is derived from either and RNA virus, an RNA phage, a messenger RNA (“mRNA”), a ribosomal RNA (“rRNA), a transfer RNA (“tRNA”), a sequence that is received as a template by one or more RNA dependent RNA polymerases, or a combination thereof. Methods disclosed herein are directed towards detecting the presence of one or more agglomeration proteins in a sample matrix using the amplibody compositions described herein.

Compositions And Methods For Binding Agglomeration Proteins

US Patent:
2005026, Dec 1, 2005
Filed:
Apr 22, 2005
Appl. No.:
11/112954
Inventors:
Abraham Grossman - Pleasantville NY, US
Valentine Kryukov - Puschino, RU
Brian Zeiler - Washington Township NJ, US
Assignee:
Q-RNA - New York NY
International Classification:
C12Q001/70
C12Q001/68
US Classification:
435005000, 435006000
Abstract:
Amplibody compositions and methods used to interact with agglomeration proteins are disclosed herein. Compositions herein comprise one or more DNA or RNA molecules having affinity for at least one agglomeration protein. The nucleic acid component is a naturally or non-naturally occuring molecule with twenty or more ribonucleotide bases. For RNA, at least one nucleotide sequence portion of this RNA molecule has affinity to at least one consensus sequence present in the agglomeration RNA-binding protein. The portion of nucleotide sequence of RNA having affinity for agglomeration proteins is a sequence that is derived from either and RNA virus, and RNA agglomeration proteins is a sequence that is derived from either and RNA virus, an RNA phage, a messenger RNA (“mRNA”), a ribosomal RNA (“rRNA”), a transfer RNA (“tRNA”), a sequence that is received as a template by one or more RNA dependent RNA polymerases, or a combination thereof. Methods disclosed herein are directed towards detecting the presence of one or more agglomeration proteins in a sample matrix using the amplibody compositions described herein.

Compositions And Methods For Binding Agglomeration Proteins

US Patent:
2006002, Feb 2, 2006
Filed:
Apr 22, 2005
Appl. No.:
11/112953
Inventors:
Abraham Grossman - Pleasantville NY, US
Valentine Kryukov - Puschino, RU
Brian Zeiler - Washington Township NJ, US
Assignee:
Q-RNA - New York NY
International Classification:
C12Q 1/70
C12Q 1/68
US Classification:
435006000, 435005000
Abstract:
Amplibody compositions and methods used to interact with agglomeration proteins are disclosed herein. Compositions herein comprise one or more DNA or RNA molecules having affinity for at least one agglomeration protein. The nucleic acid component is a naturally or non-naturally occuring molecule with twenty or more ribonucleotide bases. For RNA, at least one nucleotide sequence portion of this RNA molecule has affinity to at least one consensus sequence present in the agglomeration RNA-binding protein. The portion of nucleotide sequence of RNA having affinity for agglomeration proteins is a sequence that is derived from either and RNA virus, and RNA agglomeration proteins is a sequence that is derived from either and RNA virus, an RNA phage, a messenger RNA (“mRNA”), a ribosomal RNA (“rRNA), a transfer RNA (“tRNA”), a sequence that is received as a template by one or more RNA dependent RNA polymerases, or a combination thereof. Methods disclosed herein are directed towards detecting the presence of one or more agglomeration proteins in a sample matrix using the amplibody compositions described herein.

Methods And Kits For Making Double Stranded Ribonucleic Acids

US Patent:
2006014, Jun 29, 2006
Filed:
Dec 18, 2003
Appl. No.:
10/539850
Inventors:
Brian Zeiler - Washington Township NJ, US
Assignee:
Q-RNA, Inc. - New York NY
International Classification:
C12Q 1/68
C12P 19/34
US Classification:
435006000, 435091200
Abstract:
Embodiments of the present invention are directed to methods and kits for the generation of double stranded RNA by RNA dependent RNA polymerases. The methods and kits feature exponential generation of such RNAs through simple steps/ The RNA is suitable for interference with expression in cells.

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.